144 related articles for article (PubMed ID: 8097214)
1. A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.
Lader M; Farr I; Morton S
Int Clin Psychopharmacol; 1993; 8(1):31-6. PubMed ID: 8097214
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
[TBL] [Abstract][Full Text] [Related]
3. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
Minervini MG; Priore P; Farolfi A; Cesana B; Morselli PL
Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
[TBL] [Abstract][Full Text] [Related]
4. [Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].
Regnier F; Chastel A; L'Heritier C; Magni G; Henry M
Therapie; 1989; 44(4):279-83. PubMed ID: 2574502
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
[TBL] [Abstract][Full Text] [Related]
6. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
Lader M; Olajide D
J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
Frattola L; Piolti R; Bassi S; Albizzati MG; Cesana BM; Bottani MS; Priore P; Borghi C; Morselli PL
Clin Neuropharmacol; 1992 Dec; 15(6):477-87. PubMed ID: 1362137
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences.
Musch B; Morselli PL; Priore P
Pharmacol Biochem Behav; 1988 Apr; 29(4):803-6. PubMed ID: 2901120
[TBL] [Abstract][Full Text] [Related]
10. Studies with alpidem in normal volunteers and anxious patients.
Morton S; Lader M
Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
[TBL] [Abstract][Full Text] [Related]
11. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Morton S; Lader M
Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients.
Casacchia M; Farolfi A; Priore P; Magni G; Stratta P; Cesana B; Rossi A
Acta Psychiatr Scand; 1989 Aug; 80(2):137-41. PubMed ID: 2572145
[TBL] [Abstract][Full Text] [Related]
13. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
Morselli PL
Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence.
Perrault G; Morel E; Sanger DJ; Zivkovic B
Neuropharmacology; 1993 Sep; 32(9):855-63. PubMed ID: 7901790
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal from long-term benzodiazepine treatment.
Petursson H; Lader MH
Br Med J (Clin Res Ed); 1981 Sep; 283(6292):643-5. PubMed ID: 6114776
[TBL] [Abstract][Full Text] [Related]
16. Alpidem in the treatment of panic disorder.
Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
[TBL] [Abstract][Full Text] [Related]
17. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Mercier-Guyon C; Chabannes JP; Saviuc P
Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
19. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial.
Petrovic M; Pevernagie D; Mariman A; Van Maele G; Afschrift M
Eur J Clin Pharmacol; 2002 Jan; 57(11):759-64. PubMed ID: 11868796
[TBL] [Abstract][Full Text] [Related]
20. An imidazopyridine anxiolytic alters glucose tolerance in patients: a pilot investigation.
Bottaï T; Cartault F; Pouget R; Blayac JP; Petit P
Clin Neuropharmacol; 1995 Feb; 18(1):79-82. PubMed ID: 8665539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
